Intensive glucose control and macrovascular outcomes in type 2 diabetes.

Intensive glucose control and macrovascular outcomes in type 2 diabetes.

AIMS/HYPOTHESIS: Improved glucose control in type 2 diabetes is known to reduce the risk of microvascular events. There is, however, continuing uncertainty about its impact on macrovascular disease. The aim of these analyses was to generate more precise estimates of the effects of more-intensive, c...

Descrición completa

Detalles Bibliográficos
Main Authors:	Turnbull, F, Abraira, C, Anderson, R, Byington, R, Chalmers, J, Duckworth, W, Evans, G, Gerstein, H, Holman, R, Moritz, T, Neal, B, Ninomiya, T, Patel, A, Paul, S, Travert, F, Woodward, M
Formato:	Journal article
Idioma:	English
Publicado:	2009

Títulos similares

Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial.
por: Zoungas, S, et al.
Publicado: (2009)

Microvascular and macrovascular disease in subjects with increased but not diabetic fasting glucose levels
por: Karunakaran, S, et al.
Publicado: (1996)

The effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials
por: Zoungas, S, et al.
Publicado: (2017)

Microvascular and macrovascular disease and risk for major peripheral arterial disease in patients with type 2 diabetes
por: Woodward, M, et al.
Publicado: (2016)

Visit-to-visit Variability of Systolic Blood Pressure Predicts Macrovascular and Microvascular Events in Patients with Type 2 Diabetes: the ADVANCE Trial
por: Hata, J, et al.
Publicado: (2012)

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
por: Patel, A, et al.
Publicado: (2008)

Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: the ADVANCE trial.
por: Hata, J, et al.
Publicado: (2013)

Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: The advance trial
por: Hata, J, et al.
Publicado: (2013)

Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes
por: Mohammedi, K, et al.
Publicado: (2017)

FPG and HbA(1c) are independent risk factors for microvascular but not macrovascular complications in newly diagnosed type 2 diabetes
por: Kim, J, et al.
Publicado: (2005)

Impact of the metabolic syndrome on macrovascular and microvascular outcomes in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study 78.
por: Cull, C, et al.
Publicado: (2007)

Envolvimento macrovascular e esclerose sistêmica Macrovascular involvement and systemic sclerosis
por: Emmanuelle Tenório Albuquerque Madruga Godoi, et al.
Publicado: (2009-03-01)

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
por: Stratton, I, et al.
Publicado: (2000)

Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials.
por: Stettler, C, et al.
Publicado: (2006)

Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysis
por: Lv, J, et al.
Publicado: (2012)

Mean platelet volume (MPV) as new marker of diabetic macrovascular complications in patients with different glucose homeostasis
por: Velia Cassano, et al.
Publicado: (2024-03-01)

Micro- and Macrovascular Complications in Diabetes Mellitus: Preclinical and Clinical Studies
por: Érika B. Rangel, et al.
Publicado: (2019-01-01)

Follow-up of Intensive Glucose Control in Type 2 Diabetes Reply
por: Holman, R, et al.
Publicado: (2009)

Healthy lifestyle factors and combined macrovascular and microvascular events in diabetes patients with high cardiovascular risk: results from ADVANCE
por: Shoujiang You, et al.
Publicado: (2025-02-01)

Type 2 Diabetes Mellitus and Macrovascular Complications
por: Peng-Fei Shan, et al.
Publicado: (2017-01-01)

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study.
por: Adler, A, et al.
Publicado: (2000)

Exploring Mechanisms of Diabetes-Related Macrovascular Complications: Role of Methylglyoxal, a Metabolite of Glucose on Regulation of Vascular Contractility
por: Masashi Mukohda, et al.
Publicado: (2012-01-01)

Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials.
por: Turnbull, F, et al.
Publicado: (2008)

Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial
por: Welsh, P, et al.
Publicado: (2018)

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.
por: Patel, A, et al.
Publicado: (2007)

Molecular Mechanisms of Methylglyoxal in Diabetes-related Macrovascular Complications
por: Anna Meiliana, et al.
Publicado: (2024-10-01)

Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum?
por: Aastha Chawla, et al.
Publicado: (2016-01-01)

10-year follow-up of intensive glucose control in type 2 diabetes.
por: Holman, R, et al.
Publicado: (2008)

Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysis.
por: Jicheng Lv, et al.
Publicado: (2012-01-01)

Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds
por: Zoungas, S, et al.
Publicado: (2012)

Diabetic microvascular complications: possible targets for improved macrovascular outcomes
por: Bijan Roshan, et al.
Publicado: (2010-12-01)

Epidemiology of Micro- and Macrovascular Complications of Type 2 Diabetes in Korea
por: Jung Hee Kim, et al.
Publicado: (2011-12-01)

Potential benefit of (-)-epigallocatechin-3-gallate for macrovascular complications in diabetes
por: L. Tang, et al.
Publicado: (2017-08-01)

Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications
por: Bao Sun, et al.
Publicado: (2021-01-01)

Comments on: Microvascular and macrovascular complications in diabetes mellitus: Distinct or continuum?
por: Anubhav Chauhan, et al.
Publicado: (2016-01-01)

HIV‐Associated Cardiovascular Disease: Beyond the Macrovascular
por: Ashley B. Pournamdari, et al.
Publicado: (2023-11-01)

Symposium 13: Impact of prediabetes on macrovascular disease
por: Carolina Gómez Martin
Publicado: (2022-09-01)

Intensive glucose control improves kidney outcomes in patients with type 2 diabetes.
por: Perkovic, V, et al.
Publicado: (2013)

Supramaximal vs functional high-intensity interval training effects on macrovascular reactivity in young male athletes
por: Witid Mitranun
Publicado: (2018-06-01)

Association between diabetic nephropathy and other diabetic microvascular and macrovascular complications
por: Chandy Anila, et al.
Publicado: (2008-01-01)